Literature DB >> 12943733

The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat.

Akinobu Konishi1, Chika Tazawa, Yasuhiro Miki, Andrew D Darnel, Takashi Suzuki, Yoshio Ohta, Tsuneyuki Suzuki, Koichi Tabayashi, Hironobu Sasano.   

Abstract

In hypertension, aldosterone has been demonstrated to play a crucial role in cardiac fibrosis, which generally increases cardiac morbidity and death. However, few studies have reported the expression of the mineralocorticoid receptor (MR) and 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) in the heart under hypertensive conditions. Therefore, in this study, spontaneously hypertensive rats (SHR) were examined to elucidate the possible actions of mineralocorticoids via binding to MR. Wister Kyoto Rat (WKY), SHR, stroke-prone SHR (SHRSP), and malignant SHRSP (M-SHRSP) were used. Total RNA was extracted from the left ventricle of these rats, and examined for the expression levels of MR, 11beta-HSD2 and Collagen types 1 and 3 using reverse transcription real-time quantitative polymerase chain reaction employing the Light Cycler Instrument. Blood pressure was significantly different among each group. The mean mRNA levels for MR, 11beta-HSD2 and Collagen types 1 and 3 in M-SHRSP were found to be significantly increased compared to those of WKY, whereas no significant differences in mRNA levels were detected among SHR and SHRSP. Findings from the present study appear to demonstrate that MR and 11beta-HSD2 mRNA significantly rise in the left ventricle of M-SHRSP and increase of these mRNA is one of the cause of cardiac fibrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943733     DOI: 10.1016/s0960-0760(03)00198-5

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

Review 1.  Mineralocorticoid Receptors, Neuroinflammation and Hypertensive Encephalopathy.

Authors:  Maria Elvira Brocca; Luciana Pietranera; Edo Ronald de Kloet; Alejandro Federico De Nicola
Journal:  Cell Mol Neurobiol       Date:  2018-08-16       Impact factor: 5.046

Review 2.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 3.  Non-genomic effect of glucocorticoids on cardiovascular system.

Authors:  Sung Ryul Lee; Hyoung Kyu Kim; Jae Boum Youm; Louise Anne Dizon; In Sung Song; Seung Hun Jeong; Dae Yun Seo; Kyoung Soo Ko; Byoung Doo Rhee; Nari Kim; Jin Han
Journal:  Pflugers Arch       Date:  2012-09-23       Impact factor: 3.657

4.  Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation.

Authors:  Pei De-An; Li Li; Xu Zhi-Yun; Huang Jin-Yu; Xu Zheng-Ming; Wang Min; Yao Qiang; Huang Shi-Eng
Journal:  Clin Cardiol       Date:  2010-01       Impact factor: 2.882

5.  Tubulointerstitial de novo expression of the α8 integrin chain in a rodent model of renal fibrosis--a potential target for anti-fibrotic therapy?

Authors:  Andrea Hartner; Carlos Menendez-Castro; Nada Cordasic; Ines Marek; Gudrun Volkert; Bernd Klanke; Wolfgang Rascher; Karl F Hilgers
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

6.  Early and late postnatal myocardial and vascular changes in a protein restriction rat model of intrauterine growth restriction.

Authors:  Carlos Menendez-Castro; Fabian Fahlbusch; Nada Cordasic; Kerstin Amann; Kathrin Münzel; Christian Plank; Rainer Wachtveitl; Wolfgang Rascher; Karl F Hilgers; Andrea Hartner
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

7.  Positive effects of an extracellular matrix hydrogel on rat anterior cruciate ligament fibroblast proliferation and collagen mRNA expression.

Authors:  Rui Liang; Guoguang Yang; Kwang E Kim; Antonio D'Amore; Aimee N Pickering; Cuiling Zhang; Savio L-Y Woo
Journal:  J Orthop Translat       Date:  2015-06-25       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.